These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 1114310
1. Cyanate and sickle-cell disease. Cerami A, Peterson CM. Sci Am; 1975 Apr; 232(4):44-50. PubMed ID: 1114310 [No Abstract] [Full Text] [Related]
2. Urea, urease, cyanate, and the sickling of hemoglobin S. Nalbandian RM, Nichols BM, Stehouwer EJ, Camp FR. Clin Chem; 1972 Sep; 18(9):961-4. PubMed ID: 5052097 [No Abstract] [Full Text] [Related]
4. Cyanate as an inhibitor of red-cell sickling. Cerami A. N Engl J Med; 1972 Oct 19; 287(16):807-12. PubMed ID: 4560520 [No Abstract] [Full Text] [Related]
5. Chemical and biological aspects of the inhibition of red blood cell sickling by cyanate. Manning JM, Cerami A, Gillette PN, De Furia FG, Miller DR. Adv Exp Med Biol; 1972 Oct 19; 28():253-60. PubMed ID: 5085171 [No Abstract] [Full Text] [Related]
16. The mechanism of action of two anti-sickling agents: sodium cyanate and glyceraldehyde. Manning JM, Acharya AS. Am J Pediatr Hematol Oncol; 1984 Apr 19; 6(1):51-4. PubMed ID: 6711764 [Abstract] [Full Text] [Related]
17. Studies on abnormal hemoglobins. VI. Electrophoretic demonstration of type S (sickle cell) hemoglobin in erythrocytes incapable of showing the sickle cell phenomenon. SINGER K, FISHER B. Blood; 1953 Mar 19; 8(3):270-5. PubMed ID: 13032196 [No Abstract] [Full Text] [Related]